Newsmax Magazine: New Approach to Cancer Treatment

08/06/2024

A new type of cancer drug could transform the treatment for many deadly cancers, especially those that have advanced or metastasized and do not respond to other therapies.

Rather than killing cancer cells, as chemotherapy does, the new drug – now being studied by the Cleveland Clinic in Ohio – aims to trigger one of our main natural defenses.

CLICK HERE to read the full story from Newsmax Magazine.

READ MORE

06/04/2025

Lamassu Biotech’s dog treatment could lead to human pancreatitis breakthrough, backed by NIH funds

Lamassu Biotech, the North Carolina-based biopharmaceutical company that opened a Cleveland office last year, has received a $2.7 million grant from the National Institutes of Health to help develop its therapy for dogs with acute pancreatitis. The therapeutic, called RABI-767, also could...

READ THE ARTICLE
04/08/2025

The Washington Times: Biotech should take a page from Elon Musk’s playbookThe Washington Post:

Innovation has always been the foundation of progress, but how we innovate matters as much as the results we achieve. Recent breakthroughs in aerospace and artificial intelligence prove that massive budgets don’t drive innovation, but efficiency, speed and a relentless...

READ THE ARTICLE
11/05/2024

Cleveland.com: Biotech startup Lamassu, Cleveland Clinic aim to treat rare cancers with just three pills a month

CLEVELAND, Ohio — A biotech startup from North Carolina thinks Cleveland is where it will develop how to treat rare cancers with just three pills a month. If effective, Lamassu Biotech’s innovative gene therapy could eliminate the need for surgery or chemotherapy...

READ THE ARTICLE